Skip to main content

Clinical Trials Using Fruquintinib

Review the clinical trials studying fruquintinib on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-6 of 6

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Status: Active
Location: 8 locations
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Status: Active
Location: 7 locations
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Status: Active
Location: 3 locations
Electric Field Therapy (AM RF EMF) in Combination with Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Status: Enrolling by Invitation
Location: See ClinicalTrials.gov
Fruquintinib and Tislelizumab for the Treatment of Colorectal Cancer in Patients with Minimal Residual Disease after Chemotherapy Treatment
Status: Approved
Location: M D Anderson Cancer Center, Houston, Texas